Perceptive Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-245,332
Closed -$22.1M 113
2024
Q3
$22.1M Sell
245,332
-245,333
-50% -$20.6M 0.47% 55
2024
Q2
$38.6M Sell
490,665
-938,898
-66% -$77M 0.93% 29
2024
Q1
$125M Buy
1,429,563
+452,911
+46% +$38.7M 2.18% 12
2023
Q4
$80.5M Buy
976,652
+389,652
+66% +$29.7M 1.8% 13
2023
Q3
$46M Buy
587,000
+120,000
+26% +$10M 1.53% 20
2023
Q2
$41.1M Buy
+467,000
New +$40.2M 1.19% 25
2021
Q3
Sell
-450,000
Closed -$55.9M 149
2021
Q2
$55.9M Buy
+450,000
New +$56.5M 0.72% 40
2020
Q3
Sell
-20,000
Closed -$1.83M 138
2020
Q2
$1.83M Buy
+20,000
New +$1.92M 0.03% 105
2015
Q2
Sell
-5,000
Closed -$390K 182
2015
Q1
$390K Buy
+5,000
New +$379K 0.03% 118
2014
Q3
Sell
-130,000
Closed -$8.29M 137
2014
Q2
$8.29M Buy
+130,000
New +$7.9M 0.81% 39

Other funds holding MDT

Perceptive Advisors's MDT Position: Q4 2024 in Review

Perceptive Advisors sold out of Medtronic (MDT) in Q4 2024, closing a stake of 245,332 shares — an estimated $22.1M sold.

Perceptive Advisors first reported a position in MDT in Q2 2014 and held it in 10 quarters. The position peaked at $125M in Q1 2024. 2,124 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Perceptive Advisors reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Perceptive Advisors sold 245,332 Medtronic shares in Q4 2024, an estimated $22.1M.
  • Perceptive Advisors first reported a position in Medtronic in Q2 2014 and held it in 10 quarters.
  • Perceptive Advisors's Medtronic position peaked at $125M in Q1 2024.
  • 2,124 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Perceptive Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.